Literature DB >> 520403

Bioavailability of oral testosterone in males.

H Frey, A Aakvaag, D Saanum, J Falch.   

Abstract

Twenty-six male volunteers received a single oral dose of testosterone as free crystals or as the undecanoate ester. The latter was given either in crystalline form or in arachis oil. All preparations were tested three times in the same individual, whilst fasting on 2 days and on one day together with a breakfast rich in fat. Serum testosterone concentration was measured at intervals for up to 6--24 h after the dose. A significant and reproducible rise in serum testosterone level was found after ingestion of free testosterone. Testosterone esterified with undecylenic acid was only effective when administered in arachis oil. The meal increased the bioavailability of the ester, but had hardly any effect on that of the free hormone. It is concluded that bioavailability of oral testosterone can be improved by pharmaceutical means to an extent sufficient to produce adequate blood levels in substitution therapy.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 520403     DOI: 10.1007/BF00605634

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  16 in total

1.  Plasma testosterone values in different forms of testosterone treatment.

Authors:  A Aakvaag; J H Vogt
Journal:  Acta Endocrinol (Copenh)       Date:  1969-03

2.  Testosterone undecanoate: a new orally active androgen.

Authors:  C Hirschhäuser; C R Hopkinson; G Sturm; A Coert
Journal:  Acta Endocrinol (Copenh)       Date:  1975-09

3.  Oral testosterone, a reappraisal.

Authors:  P R Daggett; M J Wheeler; J D Nabarro
Journal:  Horm Res       Date:  1978

4.  Long-term oral testosterone and liver function.

Authors:  S G Johnsen
Journal:  Lancet       Date:  1978-01-07       Impact factor: 79.321

5.  Therapeutic effectiveness of oral testosterone.

Authors:  S G Johnsen; E P Bennett; V G Jensen
Journal:  Lancet       Date:  1974-12-21       Impact factor: 79.321

6.  The pharmacology and metabolism of testosterone undecanoate (TU), a new orally active androgen.

Authors:  A Coert; J Geelen; J de Visser; J van der Vies
Journal:  Acta Endocrinol (Copenh)       Date:  1975-08

7.  Plasma androgen levels in men after oral administration of testosterone or testosterone undecanoate.

Authors:  E Nieschlag; J Mauss; A Coert; P Kićović
Journal:  Acta Endocrinol (Copenh)       Date:  1975-06

8.  Androgen receptors in the anterior pituitary and central nervous system of the androgen "insensitive" (Tfm) rat: correlation between receptor binding and effects of androgens on gonadotropin secretion.

Authors:  O Naess; E Haug; A Attramadal; A Aakvaag; V Hansson; F French
Journal:  Endocrinology       Date:  1976-11       Impact factor: 4.736

9.  Hypogonadal men treated with oral testosterone undecanoate.

Authors:  S Sarris; G I Swyer; D M Lawrence
Journal:  Acta Eur Fertil       Date:  1977-12

10.  Plasma production rates of testosterone in normal adult men and women and in patients with the syndrome of feminizing testes.

Authors:  A L Southren; S Tochimoto; N C Carmody; K Isurugi
Journal:  J Clin Endocrinol Metab       Date:  1965-11       Impact factor: 5.958

View more
  7 in total

1.  Absolute bioavailability of testosterone after oral administration of testosterone-undecanoate and testosterone.

Authors:  L Tax
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1987 Jul-Sep       Impact factor: 2.441

Review 2.  Androgen replacement therapy: present and future.

Authors:  Louis J G Gooren; Mathijs C M Bunck
Journal:  Drugs       Date:  2004       Impact factor: 9.546

3.  Absolute bioavailability of testosterone after oral administration of testosterone-undecanoate and testosterone.

Authors:  U Täuber; K Schröder; B Düsterberg; H Matthes
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1986 Apr-Jun       Impact factor: 2.441

4.  The effect of food composition on serum testosterone levels after oral administration of Andriol Testocaps.

Authors:  Peter G Schnabel; Wilma Bagchus; Holger Lass; Torben Thomsen; T B Paul Geurts
Journal:  Clin Endocrinol (Oxf)       Date:  2007-04       Impact factor: 3.478

5.  Effect of Dose and 5α-Reductase Inhibition on the Circulating Testosterone Metabolite Profile of Men Administered Oral Testosterone.

Authors:  Abdul Basit; John K Amory; Bhagwat Prasad
Journal:  Clin Transl Sci       Date:  2018-06-19       Impact factor: 4.689

Review 6.  Intestinal lymphatic transport for drug delivery.

Authors:  Jaime A Yáñez; Stephen W J Wang; Ian W Knemeyer; Mark A Wirth; Kevin B Alton
Journal:  Adv Drug Deliv Rev       Date:  2011-06-13       Impact factor: 15.470

Review 7.  Lipid-based delivery systems and intestinal lymphatic drug transport: a mechanistic update.

Authors:  Natalie L Trevaskis; William N Charman; Christopher J H Porter
Journal:  Adv Drug Deliv Rev       Date:  2007-11-07       Impact factor: 15.470

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.